GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genfit SA (XPAR:GNFT) » Definitions » Other Operating Expense

Genfit (XPAR:GNFT) Other Operating Expense : €17.08 Mil (TTM As of Jun. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Genfit Other Operating Expense?

Genfit's Other Operating Expense for the three months ended in Jun. 2024 was €0.00 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2024 was €17.08 Mil.

Genfit's quarterly Other Operating Expense increased from Sep. 2023 (€2.82 Mil) to Dec. 2023 (€14.27 Mil) but then declined from Dec. 2023 (€14.27 Mil) to Jun. 2024 (€0.00 Mil).

Genfit's annual Other Operating Expense declined from Dec. 2021 (€4.12 Mil) to Dec. 2022 (€4.03 Mil) and declined from Dec. 2022 (€4.03 Mil) to Dec. 2023 (€0.64 Mil).


Genfit Other Operating Expense Historical Data

The historical data trend for Genfit's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genfit Other Operating Expense Chart

Genfit Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.98 0.73 4.12 4.03 0.64

Genfit Quarterly Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23 Jun24
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.10 - 2.82 14.27 -

Genfit Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €17.08 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genfit Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Genfit's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Genfit Business Description

Traded in Other Exchanges
Address
Parc Eurasante, 885, Avenue Eugene Avinee, Loos, FRA, 59120
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.